Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Use of genetic variance to identify potential therapeutic targets
Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA
Use of genetic variance to identify potential therapeutic targets ( Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA )
11 Jul 2012
Application of next generation sequencing
Dr Gary Palmer – Foundation Medicine, Cambridge, USA
Application of next generation sequencing ( Dr Gary Palmer – Foundation Medicine, Cambridge, USA )
6 Jul 2012
Importance of early detection and the ‘Beyond the Shock’ programme
Dr Douglas Feil – National Breast Cancer Foundation, USA
Importance of early detection and the ‘Beyond the Shock’ programme ( Dr Douglas Feil – National Breast Cancer Foundation, USA )
6 Jul 2012
Mouse models and proteomics tackling acute lymphoblastic leukaemia
Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland
Mouse models and proteomics tackling acute lymphoblastic leukaemia ( Prof Jean-Pierre Bourquin - University Children's Hospital Zurich, Switzerland )
25 Jun 2012
Assessing iron overload and toxicity
Prof John Porter - University College London, UK
Assessing iron overload and toxicity ( Prof John Porter - University College London, UK )
25 Jun 2012
Impressive results with a bispecific antibody for ALL
Prof Max Topp - University of Wuerzberg, Germany
Impressive results with a bispecific antibody for ALL ( Prof Max Topp - University of Wuerzberg, Germany )
21 Jun 2012
BRCA carrier status as a prognostic factor for prostate cancer
Dr Elena Castro - The Institute of Cancer Research, Sutton, UK
BRCA carrier status as a prognostic factor for prostate cancer ( Dr Elena Castro - The Institute of Cancer Research, Sutton, UK )
20 Jun 2012
Retrospective study of optimal treatment for intermediate-risk testes cancer
Dr Constantine Albany - Indiana University, Indianapolis, USA
Retrospective study of optimal treatment for intermediate-risk testes cancer ( Dr Constantine Albany - Indiana University, Indianapolis, USA )
20 Jun 2012
Open Window project improves patient quality of life
Dr Shaun McCann - St James's Hospital, Dublin, Ireland
Open Window project improves patient quality of life ( Dr Shaun McCann - St James's Hospital, Dublin, Ireland )
15 Jun 2012
Role of family history and genetic testing in diagnosis
Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis  ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved targ...
Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George	 Demetri - Dana-Farber Cancer Institute, Boston, USA )
13 Jun 2012
ASCO 2012: Advances in myeloma
Dr Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France; Prof Ga...
ASCO 2012: Advances in myeloma ( Dr Philippe Moreau - Centre Hospitalier Universitaire de Nantes, France; Prof Gareth Morgan - Royal Marsden Hospital, UK )
12 Jun 2012